Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
73,000
Siemens Healthineers AG News & Analysis
personal-finance
Simple but not easy: How to invest as Buffett intended
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,191.70 | 13.20 | 0.16% |
| CAC 40 | 8,107.49 | 13.31 | -0.16% |
| DAX 40 | 22,899.75 | 109.19 | -0.47% |
| Dow JONES (US) | 42,801.72 | 222.64 | 0.52% |
| FTSE 100 | 8,657.18 | 22.70 | -0.26% |
| HKSE | 23,783.49 | 447.81 | -1.85% |
| NASDAQ | 18,196.22 | 126.96 | 0.70% |
| Nikkei 225 | 37,028.27 | 141.10 | 0.38% |
| NZX 50 Index | 12,515.97 | 116.19 | 0.94% |
| S&P 500 | 5,770.20 | 31.68 | 0.55% |
| S&P/ASX 200 | 7,962.30 | 14.10 | 0.18% |
| SSE Composite Index | 3,366.16 | 6.38 | -0.19% |